Bruno Dubois

Institute for Memory and Alzheimer's Disease, INSERM Unit Cognition, Neuro‐imagerie et maladies due Cerveau, Groupe Hospitalier Pitie‐Salpetriere Paris France

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

2.0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The influence of diversity on the measurement of functional impairment: An international validation of the Amsterdam IADL Questionnaire in eight countries

Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring(2020)10.1002/dad2.12021

Top 15%

1.4DataRank

Top 15%28 citations

Merike Verrijp, David Facal, Gonzalo Sánchez‐Benavides, Laura J.E. Brown, Wiesje M. der Flier +16 more

Papers

Driven by 32 papers — median percentile 64. Top paper: “The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease”.

The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Alzheimer's & Dementia(2011)10.1016/j.jalz.2011.03.008

N/A

1.4DataRank · unranked

10055 citations

Steven T. DeKosky, Bruno Dubois, Howard H. Feldman, Nick C. Fox, Anthony Gamst +11 more

The influence of diversity on the measurement of functional impairment: An international validation of the Amsterdam IADL Questionnaire in eight countries

Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring(2020)10.1002/dad2.12021

Top 15%

1.4DataRank

Top 15%28 citations

Merike Verrijp, David Facal, Gonzalo Sánchez‐Benavides, Laura J.E. Brown, Wiesje M. der Flier +16 more

Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results

Movement Disorders(2008)10.1002/mds.22340

N/A

1.3DataRank · unranked

7374 citations

Barbara C. Tilley, Stephanie R. Shaftman, Glenn T. Stebbins, Stanley Fahn, Pablo Martinez‐Martin +26 more

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer's disease: an open-label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU trial

The Lancet Neurology(2025)10.1016/s1474-4422(25)00024-9

N/A

1.2DataRank · unranked

41 citations

Yan Li, Eric McDade, Jorge J. Llibre‐Guerra, David B. Clifford, Alireza Atri +62 more

Longitudinal head-to-head comparison of 11C-PiB and 18F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer’s disease

European Journal of Nuclear Medicine and Molecular Imaging(2023)10.1007/s00259-023-06209-0

N/A

0.765DataRank · unranked

24 citations

Austin McCullough, Brian A. Gordon, Nelly Joseph‐Mathurin, Shaney Flores, Nicole S. McKay +48 more

Linking self-perceived cognitive functioning questionnaires using item response theory: The subjective cognitive decline initiative.

Neuropsychology(2023)10.1037/neu0000888

Top 36%

0.546DataRank

Top 36%18 citations

the Alzheimer’s Disease Neuroimaging Initiative, Sietske A.M. Sikkes, Douglas Tommet, Richard N. Jones, Paul K. Crane +41 more

Safety and efficacy of long-term gantenerumab treatment in dominantly inherited Alzheimer’s disease: an open label extension of the phase 2/3 multicentre, randomised, double-blind, placebo-controlled platform DIAN-TU Trial

medRxiv(2024)10.1101/2024.10.29.24316289

N/A

0.351DataRank · unranked

6 citations

Yan Li, Eric McDade, Jorge J. Llibre‐Guerra, David B. Clifford, Alireza Atri +63 more

Deep learning enhanced ALPS reveals genetic and environmental factors of brain glymphatic function

eBioMedicine(2026)10.1016/j.ebiom.2026.106133

N/A

0.208DataRank · unranked

3 citations

Hao Wu, Wenbiao Xian, Yifan Zheng, Wenxuan Du, Xinyi Chen +1916 more

Brain MRI signatures across sex and CSF Alzheimer’s disease biomarkers

Brain Communications(2025)10.1093/braincomms/fcaf210

Top 78%

0.104DataRank

Top 78%1 citations

Yingnan He, Karthik Gopinath, Benjamin Billot, Juan Eugenio Iglesias, Chao‐Yi Wu +95 more

Modifiable risk factors for dementia and dementia risk profiling. A user manual for Brain Health Services—part 2 of 6

Alzheimer s Research & Therapy(2021)10.1186/s13195-021-00895-4

N/A

0DataRank · unranked

108 citations

Timothy Rittman, Shabina Hayat, Carol Brayne, Frank Jessen, Kaj Blennow +38 more

Harmonizing neuropsychological assessment for mild neurocognitive disorders in Europe

Alzheimer s & Dementia(2021)10.1002/alz.12365

N/A

0DataRank · unranked

64 citations

Andreas U. Monsch, Clarissa Ferrari, Daniele Altomare, Manfred Berres, Isabelle Bos +53 more

Awareness of Cognitive Decline in Patients With Alzheimer's Disease: A Systematic Review and Meta-Analysis

Frontiers in Aging Neuroscience(2021)10.3389/fnagi.2021.697234

N/A

0DataRank · unranked

63 citations

Marion Houot, Geoffroy Gagliardi, Bruno Dubois, Sietske A.M. Sikkes, Gonzalo Sánchez‐Benavides +5 more

Characteristics of subjective cognitive decline associated with amyloid positivity

Alzheimer s & Dementia(2021)10.1002/alz.12512

N/A

0DataRank · unranked

54 citations

Willemijn J. Jansen, Stephanie J. B. Vos, Mercè Boada, Lucilla Parnetti, Tomasz Gabryelewicz +58 more

MiRNA-15b and miRNA-125b are associated with regional Aβ-PET and FDG-PET uptake in cognitively normal individuals with subjective memory complaints

Translational Psychiatry(2021)10.1038/s41398-020-01184-8

N/A

0DataRank · unranked

32 citations

Simone Lista, Yuhai Zhao, Pablo Lemercier, Stefan Teipel, Marie‐Claude Potier +88 more

Association of plasma Aβ40/Aβ42 ratio and brain Aβ accumulation: testing a whole-brain PLS-VIP approach in individuals at risk of Alzheimer's disease

Neurobiology of Aging(2021)10.1016/j.neurobiolaging.2021.07.005

N/A

0DataRank · unranked

11 citations

Andrea Vergallo, Simone Lista, Henrik Zetterberg, Kaj Blennow, Marie‐Claude Potier +6 more

Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum

JAMA Neurology(2022)10.1001/jamaneurol.2021.5216

N/A

0DataRank · unranked

292 citations

Olin Janssen, Betty M. Tijms, Stephanie J. B. Vos, Rik Ossenkoppele, Pieter Jelle Visser +95 more

Association of APOE -Independent Alzheimer Disease Polygenic Risk Score With Brain Amyloid Deposition in Asymptomatic Older Adults

Neurology(2022)10.1212/wnl.0000000000200544

N/A

0DataRank · unranked

25 citations

Beata Gyorgy, Benjamin Grenier‐Boley, Alexandre Lecoeur, Gaëlle Fontaine, Fabrice Danjou +12 more

Dementia prevention in memory clinics: recommendations from the European task force for brain health services

The Lancet Regional Health - Europe(2023)10.1016/j.lanepe.2022.100576

N/A

0DataRank · unranked

181 citations

Daniele Altomare, Federica Ribaldi, Nicolas Villain, Carol Brayne, Naaheed Mukadam +38 more

A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer’s disease

Nature Medicine(2021)10.1038/s41591-021-01369-8

N/A

0DataRank · unranked

365 citations

Martin R. Farlow, Eric McDade, David B. Clifford, Guoqiao Wang, Jorge J. Llibre‐Guerra +61 more

Clinical diagnosis of Alzheimer's disease: recommendations of the International Working Group

The Lancet Neurology(2021)10.1016/s1474-4422(21)00066-1

N/A

0DataRank · unranked

1019 citations

Nicolas Villain, Giovanni B. Frisoni, Gil D. Rabinovici, Marwan Sabbagh, Stefano F. Cappa +15 more

The dual-path hypothesis for the emergence of anosognosia in Alzheimer’s disease

Frontiers in Neurology(2023)10.3389/fneur.2023.1239057

N/A

0DataRank · unranked

9 citations

Thomas Guieysse, Takfarinas Medani, Étienne Koechlin, Dimitrios Pantazis, Bruno Dubois +1 more

Differential response to Donepezil in MRI subtypes of mild cognitive impairment

Research Square(2023)10.21203/rs.3.rs-2485451/v1

N/A

0DataRank · unranked

1 citations

Giulia Lorenzon, Rosaleena Mohanty, Gustav Mårtensson, Enrica Cavedo, Simone Lista +8 more

The dual-path hypothesis for the emergence of anosognosia in Alzheimer's disease

arXiv (Cornell University)(2023)10.48550/arxiv.2302.05723

N/A

0DataRank · unranked

1 citations

Thomas Guiyesse, Takfarinas Medani, Étienne Koechlin, Dimitrios Pantazis, Bruno Dubois +1 more

Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation

JAMA Neurology(2024)10.1001/jamaneurol.2024.3770

N/A

0DataRank · unranked

362 citations

Nicolas Villain, Lon S. Schneider, Nick C. Fox, Noll L. Campbell, Douglas Galasko +40 more

Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis

The Lancet Neurology(2024)10.1016/s1474-4422(23)00414-3

N/A

0DataRank · unranked

63 citations

Renaud La Joie, Keir Yong, Federica Agosta, Isabel Elaine Allen, Liana G. Apostolova +82 more

Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials

The Journal of Prevention of Alzheimer s Disease(2024)10.14283/jpad.2024.61

N/A

0DataRank · unranked

4 citations

Jonathan Li, Ellen Ziegemeier, Sarah F. Adams, Eric McDade, David B. Clifford +34 more

Multidimensional classification of hippocampal shape features discriminates Alzheimer's disease and mild cognitive impairment from normal aging

UNC Libraries(2020)10.17615/dnew-zs48

N/A

0DataRank · unranked

1 citations

Stéphane Lehéricy, Marc Niethammer, Marie Chupin, Line Garnero, Bruno Dubois +7 more

Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation

UNC Libraries(2024)10.17615/pxky-1x56

N/A

0DataRank · unranked

0 citations

Lopera, Francisco, Ricardo Allegri, Nick C. Fox, Bruno Dubois, Kaj Blennow +40 more

New landscape of the diagnosis of Alzheimer's disease

The Lancet(2025)10.1016/s0140-6736(25)01294-2

N/A

0DataRank · unranked

85 citations

Oskar Hansson, Emma Nichols, Valentina Garibotto, Suzanne E. Schindler, Wiesje M. van der Flier +13 more

Accuracy of MRI Classification Algorithms in a Tertiary Memory Center Clinical Routine Cohort

Journal of Alzheimer s Disease(2020)10.3233/jad-190594

N/A

0DataRank · unranked

24 citations

Jorge Samper-Gonzalez, Anne Bertrand, Sébastian Ströer, Didier Dormont, Aline Mendes +10 more

Depressive Symptoms and Amyloid Pathology

JAMA Psychiatry(2025)10.1001/jamapsychiatry.2024.4305

N/A

0DataRank · unranked

20 citations

Julie Elisabeth Oomens, Sebastiaan Engelborghs, Chris Baeken, Christine A. F. Von Arnim, Mercè Boada +95 more

Awareness of cognitive decline trajectories in asymptomatic individuals at risk for AD

Alzheimer s Research & Therapy(2020)10.1186/s13195-020-00700-8

N/A

0DataRank · unranked

25 citations

Luisa Sambati, Marion Houot, Marie‐Odile Habert, Bruno Dubois, Stéphane Epelbaum +65 more

Bruno Dubois

Indexed papers

Top data-sharing exemplar

Papers